These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16850577)

  • 1. [Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy].
    Dimković N; Djordjević T; Popović J; Dimković S; Tirmenstajn-Janković B; Zivanović M; Bobanović-Hasković J
    Srp Arh Celok Lek; 2006; 134(1-2):44-8. PubMed ID: 16850577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E; Camerini C; Gaggia P; Zubani R; Cancarini G
    Am J Nephrol; 2018; 48(2):79-86. PubMed ID: 30071530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new treatment forInterdialytic hyperkalemia - the use of fosinopril sodium.
    Mousa D; Rassoul Z; Popovich W; Hassan A; Margate V; Hawas F; Suleiman M; Al Khader A
    Am J Nephrol; 1999; 19(3):395-9. PubMed ID: 10393377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Ribeiro SC; Figueiredo AE; Barretti P; Pecoits-Filho R; de Moraes TP;
    Am J Nephrol; 2017; 46(2):150-155. PubMed ID: 28738355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients.
    Hansson L; Forslund T; Höglund C; Istad H; Lederballe-Pedersen O; Kristinsson A; Segaard E; Svensson A; Aärynen M; Wahrenberg H; Wennersten G; Kjellström T
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):1-5. PubMed ID: 8797128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.
    Zannad F; Chati Z; Guest M; Plat F
    Am Heart J; 1998 Oct; 136(4 Pt 1):672-80. PubMed ID: 9778071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Head-to-head comparison of clinical, biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure].
    Otasević P; Putiniković B; Vukajlović Z; Ilisić B; Nesković AN
    Med Pregl; 2006; 59(1-2):51-6. PubMed ID: 17068892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients.
    Knoll GA; Sahgal A; Nair RC; Graham J; van Walraven C; Burns KD
    Am J Med; 2002 Feb; 112(2):110-4. PubMed ID: 11835948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
    Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
    Sakallı H; Baskın E; Bayrakcı US; Moray G; Haberal M
    Exp Clin Transplant; 2014 Aug; 12(4):310-3. PubMed ID: 24447308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)].
    Koch J; Greminger P; Simeon-Dubach D
    Praxis (Bern 1994); 1997 Nov; 86(45):1779-84. PubMed ID: 9446181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CMF-ECG 19/Solution. Electrolyte disturbance].
    Brunckhorst CB
    Praxis (Bern 1994); 2007 Oct; 96(43):1691-2. PubMed ID: 18019181
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS).
    Vetter W
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):255S-261S. PubMed ID: 9366282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
    Zannad F; Kessler M; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P
    Kidney Int; 2006 Oct; 70(7):1318-24. PubMed ID: 16871247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperkalemia during prolonged use of angiotensin II-converting enzyme inhibitors in end-stage renal insufficiency].
    Mooser V; Fellay G; Regamey C
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1927-9. PubMed ID: 1465596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.
    Marin R; Ruilope LM; Aljama P; Aranda P; Segura J; Diez J;
    J Hypertens; 2001 Oct; 19(10):1871-6. PubMed ID: 11593109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension.
    Wagstaff AJ; Davis R; McTavish D
    Drugs; 1996 May; 51(5):777-91. PubMed ID: 8861547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.